规范性
公司治理
危害
软件部署
数据治理
公共关系
公民新闻
社会学
管理科学
政治学
扎根理论
大数据
工程伦理学
公共政策
知识管理
通用数据保护条例
公共卫生
信息隐私
负责任的研究和创新
定性研究
业务
数字健康
公共行政
推论
能力方法
多层次治理
标识
DOI:10.1177/00914509261444387
摘要
This study examines the integration of artificial intelligence (AI) into liberal drug policy frameworks, focusing on its emerging applications, normative implications, and governance challenges. Drawing on an intersection-focused qualitative evidence synthesis combined with comparative case study analysis, the study synthesizes emerging applications in drug-use monitoring, regulated supply-chain oversight, and harm reduction. While AI offers significant potential to enhance policy responsiveness and regulatory efficiency, its deployment also raises critical concerns related to algorithmic bias, data protection, and institutional accountability. To address these tensions, the study proposes a multidimensional evaluative framework based on five criteria: effectiveness, fairness, transparency, privacy protection, and ethical alignment. The findings underscore the need for context-sensitive regulatory mechanisms that safeguard human rights, enable participatory oversight, and mitigate algorithmic harms. By integrating normative theory with structured evidence screening and comparative analysis, the study contributes a conceptually grounded framework for evaluating AI-driven governance in high-stakes public health and regulatory contexts.
科研通智能强力驱动
Strongly Powered by AbleSci AI